๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ankara
Clinical trial register · Turkey

Clinical Trials in Ankara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 5432 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:51 UTC
5432
Studies in scope
all four open statuses
2496
Recruiting now
open to new participants
552
Lead sponsors
across recruiting studies
Top sites
Istanbul 2009 Ankara 1457 Izmir 568 Adana 378 Antalya 259
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hacettepe University132 AstraZeneca102 Merck Sharp & Dohme LLC91 Ankara City Hospital Bilkent73 Ankara Etlik City Hospital64
Site location
Istanbul2009 Ankara1457 Izmir568 Adana378 Antalya259
All 319 locations
Target enrolment
to

Trials with a site in Ankara

1457 of 5432 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779Metastatic Castration-Resistant Prostate Cancer
DrugsMevrometostat·Xtandi·Enzalutamide
Pfizer
Phase 3
900
Istanbul, Izmir, Ankara
2024-10-22
Active, closed
Sensory Profile and Academic Achievement in Students
NCT06659432University Students
Gazi University
Observational
250
Ankara
2024-10-22
Active, closed
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT06321601Vasculitis
DrugAvacopan
Amgen
Phase 3
19
Ankara, Istanbul, Kayseri
2024-10-22
Active, closed
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324Metastatic Castrate Resistant Prostate Cancer (mCRPC)
DrugsMevrometostat·Xtandi·Taxotere·Enzalutamide
Pfizer
Phase 3
600
Cordaleo, Istanbul, Adana, Ankara
2024-10-21
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
NCT06623422Carcinoma, Non-Small-Cell Lung
DrugsIntismeran autogene·Pemetrexed·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
680
Sฤฑhhiye, Adapazarฤฑ, TekirdaฤŸ, Adana, Ankara, Istanbul, Kayseri, Trabzon
2024-10-21
Recruiting
Comparison of the Effects of ShoulderSphere Exercises and Bodyblade Exercises
NCT07112807Scapular Dyskinesis
Gazi University
Not applicable
45
Ankara
2024-10-21
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06662786Colorectal Neoplasms
DrugsLeucovorin calcium/Levoleucovorin·Erbitux·Amivantamab·Irinotecan
Janssen Research & Development, LLC
Phase 3
1,000
Adana, Ankara, Istanbul, Konya, Sakarya
2024-10-18
Active, closed
Investigation of Respiratory Function in Bruxism
NCT07133035Bruxism, Sleep
Atฤฑlฤฑm University
Observational
40
Ankara
2024-10-15
Recruiting
Family-Centered Physiotherapy in Dyskinetic Cerebral Palsy
NCT06532513Cerebral Palsy, Dyskinetic
Hacettepe University
Not applicable
24
Ankara
2024-10-15
Active, closed
Development of a Mobile Application and Determination of Its Effects
NCT06677476Cardiovascular Surgery, Mobile Application, Patient Education
Lokman Hekim University
Not applicable
100
Ankara
2024-10-15
Active, closed
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
NCT06564844Non-small Cell Lung Cancer
DrugsRilvegostomig·Vinorelbine·Datopotamab deruxtecan·Etoposide
AstraZeneca
Phase 3
25
Ankara, Mersin
2024-10-15
Active, closed
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
NCT06504394Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Primary Mediastinal Large B-cell Lymphoma Recurrent, Primary Mediastinal Large B-cell Lymphoma Refractory
Drugs) Berahyaluronidase alfa·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2
66
Ankara, Samsun
2024-10-14
Recruiting
LIVERAGEโ„ข: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim
Phase 3
1,800
Ankara, Bursa, Fatih, Istanbul, Izmir, Rize
2024-10-14
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
NCT06598943Ulcerative Colitis, Ulcerative Colitis Chronic
DrugsEltrekibart·Mirikizumab
Eli Lilly and Company
Phase 2
143
Ankara, Izmir, Malatya, Mersin
2024-10-10
Recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
NCT06470048Diffuse Cutaneous Systemic Sclerosis
DrugIanalumab
Novartis Pharmaceuticals
Phase 2
200
Istanbul, Ankara
2024-10-09
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
NCT06598306Extensive Stage Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 1
220
Adana, Ankara, Istanbul
2024-10-07
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression โ‰ฅ 1%
NCT06561386Non-small Cell Lung Cancer
DrugsRelatlimab·Pemetrexed·Nivolumab·Cisplatin
Bristol-Myers Squibb
Phase 3
1,000
Adana, Ankara, Istanbul
2024-10-07
Recruiting
Effects of Exercise in Patients with Lipedema
NCT06811961Lipedema
Ilke Keser
Not applicable
20
Ankara
2024-10-05
Active, closed
Clinical Performance of a Highly-filled Flowable Composite in Class III Restorations.
NCT07051551Dental Caries
Hacettepe University
Not applicable
50
Ankara
2024-10-01
Recruiting
Safe Zone in Trigger Point Injection
NCT06664359Trigger Point Pain, Myofascial
Ankara University
Observational
211
Ankara
2024-10-01
Active, closed
Childhood Migraine Treatment Noninvasive Pulsed Radiofrequency vs Flunarizine
NCT06753825Migraine Disease
DrugFlunarizine
Damla Yรผrรผk
Observational
60
Ankara
2024-10-01
Recruiting
Effects of Associated Impairments on Activity and Participation in Children With Cerebral Palsy
NCT06944171Cerebral Palsy
Hacettepe University
Observational
107
Ankara
2024-10-01
Active, closed
Investigation of the Effects of Different Exercise Approaches on Clinical Parameters in Chronic Obstructive Pulmonary Disease Patients
NCT06680960COPD (Chronic Obstructive Pulmonary Disease)
Hacettepe University
Not applicable
44
Ankara
2024-10-01
By invitation
Modified Thoracoabdominal Nerve Block(M-TAPA) in Total Laparoscopic Hysterectomies
NCT06601413Pain,Postoperative
Gulhane Training and Research Hospital
Not applicable
66
Ankara
2024-10-01
Active, closed
Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI
NCT06570759Myocardial Infarction, Myocardial Ischemia, Acute Coronary Syndrome, Diagnosis
BaลŸakลŸehir ร‡am & Sakura City Hospital
Not applicable
6,000
Ankara, Antalya, Erzurum, EskiลŸehir, Istanbul, Konya, Kรผtahya, MuฤŸla
2024-10-01
Not yet open
Turkish Validity and Reliability Study of Hospital for Special Surgery Shoulder Surgery Expectations Survey
NCT06553092Shoulder Surgery
Gazi University
Observational
100
Ankara
2024-10-01
Active, closed
A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent ฮฒ-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
NCT06421636Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals
Phase 2
19
Ankara
2024-09-30
Recruiting
The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study
NCT06166953Breast Cancer
Baskent University
Not applicable
38
Ankara
2024-09-27
Recruiting
Effect of Reformer Exercises on Pain Perception in Chronic Musculoskeletal Pain.
NCT06706037Musculoskeletal Pain
Atฤฑlฤฑm University
Not applicable
50
Ankara
2024-09-27
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
Stemline Therapeutics, Inc.
Phase 3
4,220
Adana, Sakarya, Ankara, Kadฤฑkรถy, Istanbul, Balรงova, ฤฐzmit, Konya
2024-09-27
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Atakum, Ankara, EskiลŸehir, Istanbul, Izmir
2024-09-26
Active, closed
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
NCT06525220Head and Neck Squamous Cell Carcinoma
DrugsPetosemtamab·Pembrolizumab
Merus B.V.
Phase 3
699
Ankara, Antalya, Istanbul
2024-09-25
Recruiting
Lifetech AcuMarkโ„ข Sizing Balloon Post-Market Clinical Follow-up Study
NCT06700174Atrial Septal Defect (ASD)
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
100
Ankara, Diyarbakฤฑr, Gaziantep, Istanbul, Izmir
2024-09-24
Not yet open
Assessment of the Uterus Using Ultrasonographic Elastography in Women with Dysmenorrhea
NCT06606834Primary Dysmenorrhea
Ufuk University
Observational
100
Ankara
2024-09-20
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148Geographic Atrophy, Macular Degeneration
Janssen Research & Development, LLC
Phase 2/3
274
Ankara, Izmir
2024-09-19
Active, closed
NS-050/NCNP-03 in Boys With DMD (Meteor50)
NCT06053814Duchenne Muscular Dystrophy
NS Pharma, Inc.
Phase 1/2
20
Ankara, Istanbul
2024-09-18
Active, closed
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
NCT06333951Thoracic Tumors, Non-small Cell Lung Cancer
DrugsAnvumetostat·Sotorasib·Pemetrexed·Paclitaxel
Amgen
Phase 1
49
Adana, Ankara
2024-09-17
Recruiting
Efficacy of Steroid Injection in Patients With Bifid Median Nerve Diagnosed Carpal Tunnel Syndrome
NCT06599086Carpal Tunnel Syndrome
Yunus Burak Bayฤฑr
Not applicable
40
Ankara
2024-09-15
Recruiting
HYPERTENSIVE CRISIS AND ATMOSPHERIC PRESSURE RELATIONSHIP
NCT06635603Hypertensive Urgency, Weather
Saglik Bilimleri Universitesi
Observational
350
Ankara
2024-09-15
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytrudaยฎ (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Yenimahalle, ฤฐskender, Adana, Ankara, Bursa, Gaziantep, Istanbul, Sakarya
2024-09-12
Recruiting
Myofascial Release Technique in Women With Primary Dysmenorrhea
NCT06492148Dysmenorrhea Primary, Central Sensitisation, Myofascial Trigger Point Pain, Menstrual Discomfort
Gazi University
Not applicable
36
Ankara
2024-09-10
Active, closed
A Study to Compare ABP 234 and Keytrudaยฎ (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
NCT06311721Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
DrugsABP 234·Keytruda·Pembrolizumab
Amgen
Phase 3
315
Seyhan, Keรงiรถren, Yenimahalle, ฤฐskender, Atakum, Adana, Ankara, Bursa
2024-09-09
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
NCT06548542Crohn's Disease
DrugsABBV-8736·Trosunilimab·Lutikizumab·Risankizumab
AbbVie
Phase 2
590
Dilovasฤฑ, Ankara, Istanbul, Trabzon
2024-09-04
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Bornova, Ankara, Bursa, Rize
2024-09-04
Recruiting
Sonographic Examination of Median Nerve Variations
NCT06538779Carpal Tunnel Syndrome
Yunus Burak Bayฤฑr
Observational
129
Ankara
2024-09-01
Recruiting
Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born โ‰ค 32 Weeks: A Multicenter Study
NCT06672913Premature, Skin to Skin Contact, Breast Feeding, Necrotizing Enterocolitis
Baskent University Ankara Hospital
Not applicable
120
Ankara
2024-09-01
Recruiting
Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity
NCT06592235Climate Change, Chronic Lung Disease, Air Pollution
Hacettepe University
Observational
80
Ankara
2024-09-01
Recruiting
Turkish Validity-Reliability of the Outcome Expectations For Yoga Scale
NCT06568341Adults
Hacettepe University
Observational
200
Ankara, ร‡ankฤฑrฤฑ
2024-09-01
Recruiting
Affecting Factors for Chronic Pain After Sternotomy
NCT06534372Cardiac Surgery, Sternotomy, Pain, Acute, Pain, Chronic
Ankara Etlik City Hospital
Observational
500
Ankara
2024-09-01
Active, closed
Comparison of Clinical Parameters in Chronic Obstructive Pulmonary Disease Patients and Healthy Individuals
NCT06677671COPD (Chronic Obstructive Pulmonary Disease)
Hacettepe University
Observational
20
Ankara
2024-09-01
Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
NCT06492122Metastatic Castration-resistant Prostate Cancer
DrugBlood samples for PK
Full-Life Technologies UK Limited
Phase 1
50
Ankara
2024-08-30
Active, closed
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142Immunoglobulin A Nephropathy
DrugPovetacicept
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Ankara, Istanbul, Kocaeli
2024-08-30
Recruiting
The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease
NCT06433401Congenital Heart Disease in Adolescence
Ankara Yildirim Beyazฤฑt University
Not applicable
70
Ankara
2024-08-29
Active, closed
Pain Neuroscience Education and Exercise for Chronic Nonspecific Low Back Pain
NCT07202533Chronic Non-specific Low Back Pain
Hacettepe University
Not applicable
20
Ankara
2024-08-29
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Ankara, Antalya, Izmir, ฤฐzmit, Malatya
2024-08-28
Active, closed
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT06449222Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
DrugsEribulin·Pumitamig·Gemcitabine·Paclitaxel
BioNTech SE
Phase 2
83
Adana, Adapazarฤฑ, Ankara, Istanbul
2024-08-26
Recruiting
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
NCT06041594Pulmonary Embolism
Innova Vascular, Inc.
Not applicable
107
Ankara, Istanbul, Izmir
2024-08-19
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behรงet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Ankara, Istanbul
2024-08-19
Recruiting
Exercise Capacity in Kidney Transplant Recipients
NCT06706154Renal Transplantation
Hacettepe University
Observational
27
Ankara
2024-08-17
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Bornova, Ankara
2024-08-16
Recruiting
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT06546670Sickle Cell Disease
Novartis Pharmaceuticals
Phase 1/2
161
Ankara, Adana
2024-08-15
Recruiting
Effect of Chest Tube Withdrawal on Patients' Anxiety Levels After Thoracic Surgery
NCT06531928Chest Tube Withdrawal, Video-assisted Thoracoscopic Surgery
Ankara Ataturk Sanatorium Training and Research Hospital
Observational
60
Ankara
2024-08-15
Active, closed
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT06508658Diffuse Large B-Cell Lymphoma
DrugsEpcoritamab·Lenalidomide·Rituximab·Oxaliplatin
Genmab
Phase 3
379
Ankara, Aydin, Edirne, Istanbul, Istanbul, Izmir, Samsun, ลžiลŸli, Trabzon
2024-08-13
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595Untreated Follicular Lymphoma
DrugsSurovatamig·R-Chop
AstraZeneca
Phase 3
1,018
Ankara, Istanbul, Izmir
2024-08-07
Active, closed
A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME
NCT06571045Diabetic Macular Edema (DME)
DrugsRestoret·Lucentis·Ranibizumab
EyeBiotech Ltd.
Phase 2/3
984
Ankara, Balรงova
2024-08-07
Active, closed
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
NCT06449209Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer
DrugsPumitamig·Topotecan·Etoposide·Paclitaxel
BioNTech SE
Phase 2
110
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kocaeli, Sakarya, TekirdaฤŸ
2024-08-05
Active, closed
Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension
NCT06492291Hypercholesterolemia
DrugsEnlicitide Decanoate·Enlicitide
Merck Sharp & Dohme LLC
Phase 3
3,000
Bornova, Ankara, EskiลŸehir, Kayseri, Kocaeli
2024-08-05
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
DrugsIptacopan·Rituximab
Novartis Pharmaceuticals
Phase 2
84
Istanbul, Ankara
2024-08-05
Recruiting
Efficacy of Suprascapular Radiofrequency Ablation in Hemiplegic Shoulder Pain
NCT06473389Hemiplegic Shoulder Pain
Yunus Burak Bayฤฑr
Not applicable
84
Ankara
2024-08-01
Recruiting
Digitalization of Maxillo-mandibular Relation for Arches With Occlusal Support Loss
NCT06982898Prosthetic Treatment, Occlusal Analysis, Digitalism
Kฤฑvanรง Akรงa
Not applicable
14
Ankara
2024-08-01
Recruiting
Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
NCT06796894Asthma, Respiratory Disease, Fragility
Hacettepe University
Observational
60
Ankara
2024-08-01
Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
NCT06380751Advanced Breast Cancer
DrugsSaruparib·Camizestrant·Exemestane·Anastrozole
AstraZeneca
Phase 3
788
Adapazarฤฑ, AltฤฑndaฤŸ-Ankara, Ankara, ร‡ankaya, Istanbul, Kayseri
2024-08-01
Active, closed
A Myth Orthopaedic Implant Pain in Cold Weather
NCT06909760Pain, Cold Temperature
Ankara Etlik City Hospital
Observational
210
Ankara
2024-07-31
Recruiting
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
NCT06520345Metastatic Castration-resistant Prostate Cancer
DrugsAbiraterone·Enzalutamide·Docetaxel
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
520
Ankara, Istanbul
2024-07-26
Recruiting
Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears
NCT06541756Meniscus Tear, Meniscus Lesion, Fibrin Blood Clot, Knee Injuries
Ankara City Hospital Bilkent
Not applicable
120
Ankara
2024-07-25
Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
NCT06559306Depressive Disorder, Major
DrugSeltorexant
Janssen Research & Development, LLC
Phase 3
752
Ankara, Bursa, Gaziantep, Istanbul, Kocaeli, Samsun, Trabzon
2024-07-25
Recruiting
Investigation of the Validity, Reliability, and Responsiveness of the BETY-BQ in Myositis
NCT06587724Myositis
Hacettepe University
Observational
100
Ankara
2024-07-24
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575Biliary Tract Cancer
DrugsZanidatamab·Durvalumab·Gemcitabine·Cisplatin
Jazz Pharmaceuticals
Phase 3
286
Istanbul, Ankara, Antalya, Edirne
2024-07-19
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naรฏve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT06252649Metastatic Colorectal Cancer
DrugsBevacizumab-awwb·Mvasi·Sotorasib·Panitumumab
Amgen
Phase 3
450
Adana, Ankara, Edirne, Istanbul, Izmir, Konya, Malatya
2024-07-17
Active, closed
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346Essential Thrombocythemia
DrugsBomedemstat·Hydroxyurea
Merck Sharp & Dohme LLC
Phase 3
300
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Samsun
2024-07-16
Active, closed
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
NCT06427395Primary Biliary Cholangitis
DrugSaroglitazar Magnesium
Zydus Therapeutics Inc.
Phase 3
102
AltฤฑndaฤŸ, Ankara, Bursa, Cebeli, Melikgazi
2024-07-16
Active, closed
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
NCT06161441Resectable Non-small Cell Lung Cancer
DrugsFianlimab·Paraplatin·Taxol·Cemiplimab
Regeneron Pharmaceuticals
Phase 2
195
Adana, Bornova, Kocaeli, Sakarya, Konya, Kurupelit, Gaziantep, Ankara
2024-07-16
Recruiting
Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation
NCT06756906Burn Injury, Hypoxia, Sedation
Ankara City Hospital Bilkent
Observational
70
Ankara
2024-07-15
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Ankara, Bursa, Istanbul, Konya
2024-07-12
Active, closed
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT06445023Chronic Spontaneous Urticaria
DrugBarzolvolimab
Celldex Therapeutics
Phase 3
963
Ankara, Fatih, Kocaeli, Melikgazi, Samsun, Trabzon
2024-07-11
Active, closed
Effects of Simulation Practices on Breastfeeding Knowledge and Skills of Nursing Students
NCT06643546Use of Different Simulation Techniques in Breastfeeding Education
Gulhane School of Medicine
Not applicable
157
Ankara
2024-07-01
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Ankara
2024-07-01
Recruiting
Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis
NCT06462833Osteoporosis, Postmenopausal
Gazi University
Observational
60
Ankara
2024-07-01
Recruiting
PVP-Guided Decongestive Therapy in HF 2
NCT06495892Heart Failure, Congestion, Congestive Heart Failure
BaลŸakลŸehir ร‡am & Sakura City Hospital
Phase 4
650
Ankara, Antalya, Edirne, Erzurum, EskiลŸehir, Istanbul, Izmir, KahramanmaraลŸ
2024-07-01
Recruiting
Zero Echo Time MR for the Assessment of Maxillary Sinus and Dental Regions
NCT06449443Edentulous Alveolar Ridge
Hacettepe University
Observational
20
Ankara
2024-07-01
Active, closed
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)
DrugZiltivekimab
Novo Nordisk A/S
Phase 3
10,000
Ankara, Istanbul, EskiลŸehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri
2024-06-25
Recruiting
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
NCT06463587Generalized Myasthenia Gravis
DrugCladribine
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Ankara, Atakum/SAMSUN, Istanbul, Izmir, Kocaeli, Mersin, Trabzon
2024-06-25
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374Triple-Negative Breast Cancer
DrugsXeloda·Sacituzumab tirumotecan·Keytruda·Capecitabine
Merck Sharp & Dohme LLC
Phase 3
1,530
Adana, Ankara, Istanbul, Samsun
2024-06-24
Recruiting
Feasibility and Reliability of Using BeCureTM Virtual Reality in Patients With Stroke
NCT06696469Stroke Patients
Ankara University
Observational
34
Ankara
2024-06-22
Recruiting
Ceraโ„ข Vascular Plug System Post-Market Clinical Follow-Up
NCT06099015Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation, Portal Hypertension
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
132
Adana, Ankara
2024-06-21
Active, closed
Intensive Care Unit Rehabilitation Protocols
NCT07179718Critical Illness, ICU Patients
Hacettepe University
Not applicable
24
Ankara
2024-06-21
Recruiting
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
NCT06428409Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
DrugsSacituzumab tirumotecan·Fluorouracil·Leucovorin·Adrucil
Merck Sharp & Dohme LLC
Phase 1/2
220
Ankara
2024-06-20
Active, closed
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
NCT06356129Large B-cell Lymphoma
DrugsGolcadomide·Vincristine·Doxorubicin·Prednisone
Celgene
Phase 3
850
Ankara, Izmir, Mersin, Samsun, Trabzon
2024-06-19
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288Heart Failure
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
6,712
Adana, Afyonkarahisar, Ankara, ElรขzฤฑฤŸ, Erzurum, EskiลŸehir, Gaziantep, Istanbul
2024-06-17
Recruiting
Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD
NCT06497816COPD, Health Literacy, Health-Related Behavior
Hacettepe University
Observational
144
Ankara
2024-06-15
Rows per page Showing 801–900 of 1457
Previous 7 8 9 10 11 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-turkey/city/ankara?page=9

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,432 studies in total at the last sync on 26 Sep 2026, 19:51 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,457 of those studies with a site in Ankara.

How many clinical trials are recruiting in Ankara?

706 of the 1,457 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:51 UTC sync. A further 176 have not yet opened recruitment, 513 are active but closed to new participants, and 62 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.